PENERAPAN KRITERIA SINDROM KERENTAAN PADA LANSIA DI SENTRA VAKSINASI COVID-19 DOSIS LANJUTAN UNIVERSITAS TARUMANAGARA

Main Article Content

Marcella Erwina Rumawas
Noer Saelan Tadjudin
Shirly Gunawan
Zita Atzmardina

Abstract

The advanced dose of COVID-19 vaccination aims to maintain the level of immunity and extend the period of protection against SARS-CoV-2 virus infection, given especially to vulnerable groups of people, one of which is the elderly. Currently, the number of elderly people receiving COVID-19 vaccination is still inadequate, partly due to public misinformation regarding the side effects of post-vaccination in the elderly. It has been known that vaccination in the elderly must be carried out with extra care because of the frailty of the elderly.  Therefore, to ensure that vaccination for the elderly is effective and optimal, the feasibility of receiving a COVID-19 vaccination needs to be determined through screening for frailty syndromes. The advanced-dose COVID-19 Vaccination Center at Tarumanagara University, in partnership with the Grogol Petamburan District Health Center, West Jakarta, was held on February 2-4, 2022. Besides the general criteria for vaccination, which included history of diseases and the results of measuring body temperature and blood pressure, the medical team from the Faculty of Medicine Tarumanagara University applied the criteria for frailty syndrome to the elderly, namely difficulty climbing 10 stairs or walking 100-200 meters, often feeling tired, have at least 5 of 11 chronic diseases and experienced significant weight loss in the past year. Elderly was not eligible to receive COVID-19 vaccine if there were >2 conditions of vulnerability were found.  Of the 45 elderly who took part in the activity, none had a frailty condition >2, so a further dose of COVID-19 vaccination could be given.


ABSTRAK:


Vaksinasi COVID-19 dosis lanjutan bertujuan untuk mempertahankan tingkat kekebalan serta memperpanjang masa perlindungan terhadap infeksi virus SARS-CoV-2, diberikan terutama pada kelompok masyarakat rentan, salah satunya adalah lansia. Saat ini jumlah lansia yang menerima vaksinasi COVID-19 belum memadai, diantaranya disebabkan media informasi publik mengenai efek samping pasca vaksinasi pada lansia.  Telah diketahui bahwa vaksinasi pada lansia harus dilakukan dengan ekstra hati-hati karena adanya kondisi kerentaan (frailty) pada lansia.  Sebab itu, untuk memastikan pemberian vaksinasi pada lansia efektif dan optimal, kelayakan menerima vaksinasi COVID-19 perlu ditentukan melalui penapisan sindrom kerentaan.  Sentra Vaksinasi   COVID-19 dosis lanjutan di Universitas Tarumanagara, bermitra dengan Puskesmas Kecamatan Grogol Petamburan Jakarta Barat, diselenggarakan pada tanggal 2-4 Februari 2022. Selain kriteria umum layak vaksinasi yang mencakup hasil pengukuran suhu tubuh dan tekanan darah serta riwayat penyakit, tim medis dari Fakultas Kedokteran Universitas Tarumanagara menerapkan kriteria sindrom kerentaan pada sasaran lansia, yaitu kesulitan naik 10 anak tangga, kesulitan berjalan 100-200 meter, sering merasa kelelahan, memiliki minimal 5 dari 11 penyakit kronik dan mengalami penurunan berat badan yang bermakna dalam setahun terakhir.  Jika didapatkan >2 kondisi kerentaan, maka lansia belum layak divaksinasi COVID-19. Dari 45 lansia yang menghadiri kegiatan tersebut, tidak didapatkan lansia dengan kondisi renta >2 sehingga dinyatakan layak diberikan vaksinasi COVID-19 dosis lanjutan.


 

Article Details

How to Cite
Rumawas, M. E., Tadjuddin, N. S., Gunawan, S., & Atzmardina, Z. (2023). PENERAPAN KRITERIA SINDROM KERENTAAN PADA LANSIA DI SENTRA VAKSINASI COVID-19 DOSIS LANJUTAN UNIVERSITAS TARUMANAGARA. Jurnal Bakti Masyarakat Indonesia, 5(3). https://doi.org/10.24912/jbmi.v5i3.20393
Section
Articles

References

Badan Pusat Statisik. (2021). Jumlah Penduduk Jakarta Barat, 2018-2020. Retrieved 15 April 2022, from https://jakbarkota.bps.go.id/indicator/12/48/1/jumlah-penduduk-jakarta-barat-kelompok-umur.html

Fuentes, E., Fuentes, M., Alarcon, M., & Palomo, I. (2017, Jan-Mar). Immune System Dysfunction in the Elderly. An Acad Bras Cienc, 89(1), 285-299. https://doi.org/10.1590/0001-3765201720160487

Hall, V., Foulkes, S., Insalata, F., Kirwan, P., Saei, A., Atti, A., Wellington, E., Khawam, J., Munro, K., Cole, M., Tranquillini, C., Taylor-Kerr, A., Hettiarachchi, N., Calbraith, D., Sajedi, N., Milligan, I., Themistocleous, Y., Corrigan, D., Cromey, L., Price, L., Stewart, S., de Lacy, E., Norman, C., Linley, E., Otter, A. D., Semper, A., Hewson, J., D'Arcangelo, S., Chand, M., Brown, C. S., Brooks, T., Islam, J., Charlett, A., Hopkins, S., & Group, S. S. (2022, Mar 31). Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection. N Engl J Med, 386(13), 1207-1220. https://doi.org/10.1056/NEJMoa2118691

Harapan, H., Wagner, A. L., Yufika, A., Winardi, W., Anwar, S., Gan, A. K., Setiawan, A. M., Rajamoorthy, Y., Sofyan, H., & Mudatsir, M. (2020). Acceptance of a COVID-19 Vaccine in Southeast Asia: A Cross-Sectional Study in Indonesia. Front Public Health, 8, 381. https://doi.org/10.3389/fpubh.2020.00381

Kemenkes R.I. (2022a). Penyesuaian pelaksanaan vaksinasi COVID-19 dosis lanjutan (booster) bagi lansia. Retrieved 22 Februari 2022, from https://covid19.go.id/storage/app/media/Regulasi/2022/Februari/6.%20Penyesuaian% 20Pelaksanaan%20Booster%20Lansia%20edit.pdf

Kemenkes R.I. (2022b). Surat edaran No: HK.02.02.II/252/2022 tentang vaksinasi COVID-19 dosis lanjutan (booster). Retrieved 26 Februari 2022, from https://covid19.go.id/storage/app/media/Regulasi/2022/Januari/surat-edaran-vaksinasi-covid-19-dosis-lanjutan-booster.pdf

Kemenkes R.I. (2022c). Vaksinasi COVID-19 Nasional (Data per tanggal 26 Februari 2022 Pukul 12.00 WIB). Retrieved 26 Februari 2022, from https://vaksin.kemkes.go.id/#/vaccines

Perhimpunan Dokter Spesialis Penyakit Dalam Indonesia. (2021). Rekomendasi PAPDI tentang Pemberian Vaksinasi COVID-19 pada Pasien dengan Penyakit Penyerta/ Komorbid (Revisi 18 Maret 2021). Retrieved 23 September 2022, from https://www.papdi.or.id/berita/info-papdi/1024-rekomendasi-papdi-tentang-pemberian-vaksinasi-covid-19-pada-pasien-dengan-penyakit-penyerta-komorbid-revisi-18-maret-2021#

Perhimpunan Gerontologi Medik Indonesia. (2021). Rekomendasi dan skrining pada pemberian vaksin COVID-19 untuk lansia. Retrieved 22 Februari 2022, from https://www.dpr.go.id/pengumuman/PERGEMI_Sosialisasi%20vaksin%20kesga%20lansia%2023%20dan%2024%20Februari%202021.pdf

Soiza, R. L., Scicluna, C., & Thomson, E. C. (2021, Feb 26). Efficacy and safety of COVID-19 vaccines in older people. Age Ageing, 50(2), 279-283. https://doi.org/10.1093/ageing/afaa274

Surendra, H., Elyazar, I. R., Djaafara, B. A., Ekawati, L. L., Saraswati, K., Adrian, V., Widyastuti, Oktavia, D., Salama, N., Lina, R. N., Andrianto, A., Lestari, K. D., Burhan, E., Shankar, A. H., Thwaites, G., Baird, J. K., & Hamers, R. L. (2021, Apr). Clinical characteristics and mortality associated with COVID-19 in Jakarta, Indonesia: A hospital-based retrospective cohort study. Lancet Reg Health West Pac, 9, 100108. https://doi.org/10.1016/j.lanwpc.2021.100108

Tan, L. F., Alicia, A. X. Y., & Wei, C. J. (2021, Jul). The Challenges of Vaccinating Frail Older Adults Against COVID-19 In A Low-Incidence Country. Lancet Reg Health West Pac, 12, 100192. https://doi.org/10.1016/j.lanwpc.2021.100192

Universitas Tarumanagara. (2022). Visi Misi dan Tujuan. Retrieved 22 Februari 2022, from http://untar.ac.id/pages/visimisi

Most read articles by the same author(s)